Security · CUSIP 03753UAB2
APELLIS PHARMACEUTICALS INC
NOTE 3.500% 9/1 · institutional ownership from 13F filings
13F holders
2
Shares held
11.7M
Value held
$28.0M
New / sold out
0 / 0
Added / reduced
1 / 0
net +2.1M shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2023
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| LORD, ABBETT & CO. LLC | 11,712,000 | $28.0M | 0.05% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| LORD, ABBETT & CO. LLC | Added | +2,100,000 | +21.8% |
Biggest sellers
Nothing to show.